Literature DB >> 12704211

Early expression of bone matrix proteins in osteogenic cell cultures.

Paulo Tambasco de Oliveira1, Sylvia Francis Zalzal, Kazuharu Irie, Antonio Nanci.   

Abstract

Osteogenic cells express some matrix proteins at early culture intervals. The aim of this study was to determine if, and in what proportion, cells used for plating contain bone sialoprotein (BSP) and osteopontin (OPN), two matrix proteins associated with initial events in bone formation. Their pattern of expression, as well as that of fibronectin (FN) and type I pro-collagen, was also examined at 6 hr and at 1 and 3 days. The cells were obtained by enzymatic digestion of newborn rat calvariae, and grown on glass coverslips. Cytocentrifuge preparations of isolated cells and coverslips were processed for single or dual immunolabeling with monoclonal and/or polyclonal primary antibodies, followed by fluorochrome-conjugated antibodies. The cell labeling was mainly associated with perinuclear elements. OPN was also distinctively found at peripheral cytoplasmic sites. About 31% of isolated cells were OPN-positive and 18% were BSP-positive. After 1 day, almost 50% of cells were immunoreactive for OPN and for type I pro-collagen, and still less than 20% reacted for BSP. Approximately 7% exhibited peripheral staining for OPN. Almost all cells were associated with extracellular FN. However, only 15% showed intracellular labeling. These results indicate that an important proportion of cells used for plating contain BSP and OPN, a situation that should be taken into consideration in experimental analyses of osteoblast activity in vitro.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704211     DOI: 10.1177/002215540305100509

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  8 in total

1.  Effects of low-level laser therapy (685 nm) at different doses in osteogenic cell cultures.

Authors:  Humberto Osvaldo Schwartz-Filho; Aline C Reimer; Claudio Marcantonio; Elcio Marcantonio; Rosemary Adriana C Marcantonio
Journal:  Lasers Med Sci       Date:  2011-03-09       Impact factor: 3.161

2.  GATA4 regulates osteoblastic differentiation and bone remodeling via p38-mediated signaling.

Authors:  Tingting Zhou; Shuyu Guo; Yuxin Zhang; Yajuan Weng; Lin Wang; Junqing Ma
Journal:  J Mol Histol       Date:  2017-04-09       Impact factor: 2.611

3.  Effect of antiresorptive drugs in the alveolar bone healing. A histometric and immunohistochemical study in ovariectomized rats.

Authors:  Gabriel Ramalho-Ferreira; Leonardo Perez Faverani; Gustavo Antonio Correa Momesso; Eloá Rodrigues Luvizuto; Igor de Oliveira Puttini; Roberta Okamoto
Journal:  Clin Oral Investig       Date:  2016-07-27       Impact factor: 3.573

4.  Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1β, TNF-α, and IFN-γ.

Authors:  Laura E Sidney; Glen R Kirkham; Lee D Buttery
Journal:  Stem Cells Dev       Date:  2014-01-23       Impact factor: 3.272

5.  Mast Cell Mediators Inhibit Osteoblastic Differentiation and Extracellular Matrix Mineralization.

Authors:  William Marcatti Amarú Maximiano; Elaine Zayas Marcelino da Silva; Ana Carolina Santana; Paulo Tambasco de Oliveira; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2017-10-05       Impact factor: 2.479

6.  Effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells.

Authors:  Daniela B Palioto; Thaisângela L Rodrigues; Julie T Marchesan; Márcio M Beloti; Paulo T de Oliveira; Adalberto L Rosa
Journal:  Head Face Med       Date:  2011-07-18       Impact factor: 2.151

7.  Meeting report on the 12th International Congress of Histochemistry and Cytochemistry (ICHC).

Authors:  Maria De Falco; Antonio De Luca
Journal:  J Cell Physiol       Date:  2005-08       Impact factor: 6.384

8.  Rap1A Regulates Osteoblastic Differentiation via the ERK and p38 Mediated Signaling.

Authors:  Yougen Wu; Juan Zhou; Yinghua Li; Yunjiao Zhou; Yunqing Cui; Gong Yang; Yang Hong
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.